Ultrasound with contrast for prostate cancer detection
Part of Cancer, Kidney & urinary clinical trials.
This study tests whether a special ultrasound with a contrast dye can help doctors find clinically significant prostate cancer during a biopsy. The goal is to better target the biopsy, which may lead to more accurate diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for a prostate biopsy because of a high or rising PSA blood test, or an abnormal physical exam.
- You are a male aged 18 or older.
- You have not been treated for prostate cancer before, including hormone therapy.
- You are not allergic to the ultrasound contrast agent (Definity) or its ingredients.
- You have not taken part in a drug trial within the last 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a new imaging agent (flotufolastat F 18 PET CT) can find prostate cancer better than MRI. If you have a suspicious spot on an MRI, this study may help doctors see if the new scan is more accurate.
This trial compares a new micro-ultrasound technique to standard ultrasound during prostate biopsy, using MRI results as a guide. It aims to see if the newer method finds cancer more accurately.
This trial tests a new imaging scan that combines a special PET tracer with MRI to help guide a prostate biopsy. The goal is to see if this scan can more accurately find cancer and reduce the need for extra biopsies.
This study tests a new urine test combined with an MRI to find prostate cancer early. It may help avoid unnecessary biopsies.
This trial tests a new, detailed ultrasound technique that uses a contrast agent (called Definity) to get clearer images of a suspicious area before a biopsy. It may help doctors better see the blood flow in the lesion, which could improve diagnosis.
This trial uses a special ultrasound with a contrast agent to take detailed images of the prostate before surgery. It may help doctors see the cancer more clearly and plan the best treatment.
Hear when a new Prostate Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.